O. Bonne et al., INCREASED CEREBRAL BLOOD-FLOW IN DEPRESSED-PATIENTS RESPONDING TO ELECTROCONVULSIVE-THERAPY, The Journal of nuclear medicine, 37(7), 1996, pp. 1075-1080
Considerable data support the existence of impaired regional cerebral
blood flow (rCBF) in major depression. We compared rCBF in depressed p
atients before and after electroconvulsive therapy (ECT) to define whe
ther the impairment is a ''state''-related property or a trait phenome
non. Methods: Twenty patients with a major depressive disorder were st
udied by Tc-99m-HMPAO brain SPECT, 2-4 days before and 5-8 days after
a course of ECT. Three transaxial brain slices delineating anatomicall
y defined regions of interest at approximately 4, 6 and 7 cm above the
orbitomeatal line were used, with the average number of counts for ea
ch region of interest normalized to the area of maximal cerebellar upt
ake. Results: Technetium-99m-HMPAO uptake significantly increased in p
atients who responded to ECT but remained unchanged in patients who di
d not respond to the treatment (response defined as a reduction of at
least 60% on the Hamilton Depression Rating Scale). An inverse correla
tion was observed between severity of depression and HMPAO uptake, and
clinical improvement was positively correlated with the increase in t
racer uptake. Conclusions: These findings imply that reduced rCBF in d
epression, as reflected in brain Tc-99m-HMPAO uptake, is a ''state''-r
elated property and is reversible by successful treatment. Technetium-
99m-HMPAO uptake may serve as an objective state marker for depression
, as an indicator of the severity of depression and as an objective me
ans of evaluating response to treatment.